These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7119789)

  • 1. Concentrations of GABA and other amino acids in CSF from torsion dystonia patients.
    Perry TL; Hansen S; Quinn N; Marsden CD
    J Neurochem; 1982 Oct; 39(4):1188-91. PubMed ID: 7119789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GABA and amino acid concentrations in lumbar CSF in patients with treated and untreated epilepsy.
    Crawford PM; Chadwick DW
    Epilepsy Res; 1987; 1(6):328-38. PubMed ID: 3504408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine beta-hydroxylase activity in cerebrospinal fluid of idiopathic torsion dystonia.
    Park DH; Kang UJ; Moskowitz CB; Burke RE; Joh TH; Fahn S
    Neurology; 1990 Oct; 40(10):1626-8. PubMed ID: 2215959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human CSF GABA concentrations: revised downward for controls, but not decreased in Huntington's chorea.
    Perry TL; Hansen S; Wall RA; Gauthier SG
    J Neurochem; 1982 Mar; 38(3):766-73. PubMed ID: 6460090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of vigabatrin (gamma-vinyl GABA) on amino acid levels in CSF of epileptic patients.
    Pitkänen A; Matilainen R; Ruutiainen T; Lehtinen M; Riekkinen P
    J Neurol Neurosurg Psychiatry; 1988 Nov; 51(11):1395-400. PubMed ID: 2853206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of delta-aminobutyric acid and other amino acids in cerebrospinal fluid of pediatric patients by reversed-phase liquid chromatography.
    Goldsmith RF; Earl JW; Cunningham AM
    Clin Chem; 1987 Oct; 33(10):1736-40. PubMed ID: 2889543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF gradients for amino acid neurotransmitters.
    Crawford PM; Lloyd KG; Chadwick DW
    J Neurol Neurosurg Psychiatry; 1988 Sep; 51(9):1193-200. PubMed ID: 2906363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoniazid-induced alteration of CSF neurotransmitter amino acids in Huntington's disease.
    Manyam BV; Ferraro TN; Hare TA
    Brain Res; 1987 Apr; 408(1-2):125-30. PubMed ID: 2885064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of free gamma-aminobutyric acid and other neuroactive amino acids in cerebrospinal fluid of patients with neurological disorders.
    Doroshenko Ye M; Kulesh SD
    Ukr Biokhim Zh (1978); 1996; 68(5):89-94. PubMed ID: 9229859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in the free amino acid spectrum in torsion dystonia patients].
    Sukhorebraia LA; Pesnia VV; Markova ED; Dukarskiĭ FG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(10):1463-6. PubMed ID: 930490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of enzyme-mediated alterations of gamma-aminobutyric acid content in human CSF.
    Hare TA; Wood JH; Manyam BV
    Arch Neurol; 1981 Aug; 38(8):491-4. PubMed ID: 7247786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low cerebrospinal fluid gamma-aminobutyric acid content in seizure patients.
    Wood JH; Hare TA; Glaeser BS; Ballenger JC; Post RM
    Neurology; 1979 Sep; 29(9 Pt 1):1203-8. PubMed ID: 113694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further characterization of in vitro conditions appropriate for GABA determination in human CSF: impact of acid deproteinization and freeze/thaw.
    Ferraro TN; Manyam BV; Hare TA
    J Neurochem; 1983 Oct; 41(4):1057-64. PubMed ID: 6225837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring of gamma-aminobutyric acid in human cerebrospinal fluid: downward revision of previous control values.
    Löscher W; Schmidt D
    Ther Drug Monit; 1984; 6(2):227-31. PubMed ID: 6740742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of amino acid content of cerebrospinal fluid from patients with epilepsy.
    Araki K; Harada M; Ueda Y; Takino T; Kuriyama K
    Acta Neurol Scand; 1988 Dec; 78(6):473-9. PubMed ID: 3223234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Huntington's disease. Cerebrospinal fluid GABA levels in at-risk individuals.
    Manyam NV; Hare TA; Katz L; Glaeser BS
    Arch Neurol; 1978 Nov; 35(11):728-30. PubMed ID: 152621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory and excitatory neurotransmitters in the cerebrospinal fluid of epileptic dogs.
    Ellenberger C; Mevissen M; Doherr M; Scholtysik G; Jaggy A
    Am J Vet Res; 2004 Aug; 65(8):1108-13. PubMed ID: 15334845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of amino acid neurotransmitters, related compounds, and precursors in dystonia.
    Manyam BV; Ferraro TN; Hare TA
    Adv Neurol; 1988; 50():203-9. PubMed ID: 2899949
    [No Abstract]   [Full Text] [Related]  

  • 19. Concentration gradients of free and total gamma-aminobutyric acid and homocarnosine in human CSF: comparison of suboccipital and lumbar sampling.
    Grove J; Schechter PJ; Hanke NF; de Smet Y; Agid Y; Tell G; Koch-Weser J
    J Neurochem; 1982 Dec; 39(6):1618-22. PubMed ID: 7142991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gamma-aminobutyric acid (GABA) in the CSF of schizophrenic patients before and after neuroleptic treatment.
    Lichtshtein D; Dobkin J; Ebstein RP; Biederman J; Rimon R; Belmaker RH
    Br J Psychiatry; 1978 Feb; 132():145-8. PubMed ID: 623945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.